IL-10 and TGF-β cooperate in the regulatory T cell response to mucosal allergens in normal immunity and specific immunotherapy

European Journal of Immunology

Volumn 33, Issue 5, 2003, Pages 1205-1214

  Jutel, Marek ^a,b   Akdis, Mübeccel ^a   Budak, Ferah ^c   Aebischer Casaulta, Carmen ^c,d   Wrzyszcz, Maria ^b   Blaser, Kurt ^a   Akdis, Cezmi A ^a  

^a SWISS INSTITUTE OF ALLERGY AND ASTHMA RESEARCH SIAF   (Switzerland)

^b WROCLAW MEDICAL UNIVERSITY   (Poland)

^c ULUDAG UNIVERSITY   (Turkey)

^d UNIVERSITY OF BERN   (Switzerland)

Author keywords

IL 10; Regulatory T cell; Specific immunotherapy; T cell; TGF

Indexed keywords

ALLERGEN; ANTIHISTAMINIC AGENT; CD4 ANTIGEN; CORTICOSTEROID; CYTOKINE; GAMMA INTERFERON; HOUSE DUST ALLERGEN; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 5; NOVOHELISEN; POLLEN ANTIGEN; TRANSFORMING GROWTH FACTOR BETA;

ADULT; AIRBORNE PARTICLE; ALLERGIC REACTION; ANTIGEN SPECIFICITY; ARTICLE; ASTHMA; CELLULAR IMMUNITY; CLINICAL ARTICLE; CYTOKINE RELEASE; HUMAN; IMMUNOREGULATION; IMMUNOTHERAPY; LYMPHOCYTE PROLIFERATION; MUCOSAL IMMUNITY; PRIORITY JOURNAL; RHINITIS; T LYMPHOCYTE; TH1 CELL; TH2 CELL;

ADULT; ALLERGENS; ANTIGENS, DERMATOPHAGOIDES; CELLS, CULTURED; HUMANS; IMMUNE TOLERANCE; IMMUNITY, MUCOSAL; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOTHERAPY; INTERLEUKIN-10; T-LYMPHOCYTES; TRANSFORMING GROWTH FACTOR BETA;

EID: 0038363534     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200322919     Document Type: Article

References (57)

1. Mosmann, T. R. and Sad, S., The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol. Today 1996. 17: 138-146.
2. Romagnani, S., Lymphokine production by human T cells in disease states. Annu. Rev. Imunol. 1994. 12: 227-257.
3. Abbas, A. K., Murphy, K. M. and Sher, A., Functional diversity of helper T lymphocytes. Nature 1996. 383: 787-793.
4. Paul, W. E. and Seder, R. A., Lymphocyte responses and cytokines. Cell 1994. 76: 241-251.
5. Kapsenberg, M. L., Jansen, H. M., Bos, J. D. and Wierenga, E. A., Role of type 1 and type 2 T helper cells in allergic diseases. Curr. Opin. Immunol. 1992. 4: 788-794.
6. Holt, P. G., Key factors in the development of asthma: atopy. Am. J. Respir. Crit. Care Med. 2000. 161: 172-175.
7. Simon, H. U. and Blaser, K., Inhibition of programmed eosinophil death: a key of pathogenic event for eosinophilia? Immunol. Today 1995. 16: 53-55.
8. Spiegelberg, H. L., Beck, L., Kocher, H. P., Fanslow, W. C. and Lucas, A. H., Role of interleukin-4 in human immunoglobulin E formation in hu-PBL-SCID mice. J. Clin. Invest. 1994. 93: 711-717.
9. Punnonen, J., Aversa, G., Cocks, B. G., Mc Kenzie, A. N. J., Menon, S., Zurawski, G., De Waal Malefyt, R. and De Vries, J. E., Interleukin-13 induces interleukin-4 independent IgG4 and IgE synthesis and CD23 expression by human B cells. Proc. Natl. Acad. Sci U S A 1993. 90: 3730-3734.
10. Hamelmann, E. and Gelfand, E. W., IL-5-induced airway eosinophila - the key to asthma? Immunol. Rev. 2001. 179: 182-191.
11. Aalberse, R. C., van der Gaag, R. and van Leuwen, J., Serologic aspects of IgG4 antibodies. I. Prolonged immunization results in an IgG4-restricted response. J. Immunol. 1983. 130: 722-726.
12. Akdis, C. A., Blesken, T., Akdis, M., Alkan, S. S., Wüthrich, B., Heusser, C. H. and Blaser, K., Induction and differential regulation of bee venom phospholipase A2-specific human IgE and IgG4 antibodies in vitro requires allergen-specific and nonspecific activation of T and B cells. J. Allergy Clin. Immunol. 1997. 99: 345-353.
13. Carballido, J. M., Carballido-Perrig, N., Oberli-Schrämmli, A., Heusser, C. H. and Blaser, K., Regulation of IgE and IgG4 responses by allergen-specific T-cell clones to bee venom phospholipase A2 in vitro. J. Allergy Clin. Immunol. 1994. 93: 758-767.
14. Punnonen, J. R., de Waal Malefyt, R., van Vlasserlaer, P., Gauchat, J. F. and De Vries, J. E., IL-10 and viral IL-10 prevent IL-4-induced IgE synthesis by inhibiting the accessory cell function of monocytes. J. Immunol. 1993. 151: 1280-1289.
15. Akdis, C. A., Blesken, T., Akdis, M., Wuthrich, B. and Blaser, K., The role of IL-10 in specific immunotherapy. J. Clin. Invest. 1998. 102: 98-106.
16. Fiorentino, D. F., Zlotnik, A., Mosmann, T. R., Howard, M. and O'Garra, A., IL-10 inhibits cytokine production by activated macrophages. J. Immunol. 1991. 147: 3815-3822.
17. De Waal Malefyt, R., Abrams, J., Bennett, B., Figdor, C. G. and de Vries, J. E., Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J. Exp. Med. 1991. 174: 1209-1220.
18. Hsu, D. H., Moore, K. W. and Spits, H., Differential effects of interleukin-4 and -10 on interleukin-2 induced interferon-γ synthesis and lymphokine activated killer activity. Int. Immunol. 1992. 4: 563-569.
19. Del Prete, G., DeCarli, M., Almerigogna, F., Giudizi, M. G., Biagiotti, R. and Romagnani, S., Human IL-10 is produced by both type 1 helper (Th1) and type 2 helper (Th2) T cell clones and inhibits their antigen-specific proliferation and cytokine production. J. Immunol. 1993. 150: 353-360.
20. Schandene, L., Alonso-Vega, C., Willems, F., Gerard, C., Delvaux, A., Velu, T., Devos, R., de Boer, M. and Goldman, M., B7/CD28-dependent IL-5 production by human resting T cells is inhibited by IL-10. J. Immunol. 1994. 152: 4368-4374.
21. Kehrl, J. H., Wakefield, L. M., Roberts, A. B., Jakowlew, S., Alvarez-Mon, M., Derynck, R., Sporn, M. B. and Fauci, A. S., Production of transforming growth facor-β by human T lymphocytes and its potential role in the regulation of T cell growth. J. Exp. Med. 1986. 163: 1037-1050.
22. + T cells requires the coordinate action of interleukin-12 and interferon-gamma and is inhibited by transforming growth factor-β. Eur. J. Immunol. 1994. 24: 793-799.
23. Fargeas, C., Wu, C.Y., Nakajima, T., Cox, D., Nutman, T. and Delespesse, G., Differential effect of transforming growth factor-β on the synthesis of Th1- and Th2-like lymphokines by human T lymphocytes. Eur J. Immunol. 1992. 22: 2173-2176.
24. Nagelkerten, L., Gollob, K. J., Tielemans, M. and Coffman, R., Role of transforming growth factor-β in the preferential induction of T helper cells of type 1 by staphyloccocal enterotoxin B. Eur. J. Immunol. 1993. 23: 2306-2310.
25. + Th1/Th2 cells. Eur J. Immunol. 2000. 30: 2101-2111.
26. Zhang, X., Giangreco, L., Broome, H. E., Dargan, C. M. and Swain, S. L., Control of CD4 effector fate: transforming growth factor-β1 and interleukin 2 synergize to prevent apoptosis and promote effector expansion. J. Exp. Med. 1995. 182: 699-709.
27. Geiser, A. G., Letterio, J. J., Kulkarni, A. B., Karlsson, S., Roberts, A. B. and Sporn, M. B., Transforming growth factor-β1 (TGF-β1) controls expression of major histocompatibility genes in the postnatal mouse: aberrant histocompatiblity antigen expression in the pathogenesis of the TGF-β1 null mouse phenotype. Proc. Natl. Acad. Sci. U S A 1993. 90: 9944-9948.
28. Takeuchi, M., Alard, P. and Streilein, J.W., TGF-β promotes immune deviation by altering accessory signals of antigen presenting cell. J. Immunol. 1998. 160: 1589-1597.
29. Letteiro, J. J. and Roberts, A. B., Regulation of immune responses by TGF-β. Annu. Rev. Immunol. 1998. 16: 137-161.
30. Cazac, B. B. and Roes, J., TGFβ receptor controls B cell responsiveness and induction of IgA in vivo. Immunity 2000. 13: 443-451.
31. Secrist, H., Chelen, C. J., Wen, Y., Marshall, J. D. and Umetsu, D. T., Allergen immunotherapy decreases interleukin 4 production in CD4 T cells from allergic individuals. J. Exp. Med. 1993. 178: 2123-2130.
32. Varney, V. A., Hamid, Q. A., Gaga, M., Ying, S., Jacobson, M., Frew, A. J., Kay, A. B. and Durham, S. R., Influence of grass pollen immunotherapy on cellular infiltration and cytokine mRNA expression during allergen-induced late phase cutaneos responses. J. Clin. Invest. 1993. 92: 644-651.
33. Jutel, M., Pichler, W. J., Skrbic, D., Urwyler, A., Dahinden, C. and Müller, U. R., Bee venom immunotherapy results in decrease of IL-4 and IL-5 and increase of IFN-γ secretion in specific allergen stimulated T cell cultures. J. Immunol. 1995. 154: 4187-4194.
34. + T cells. J. Allergy Clin. Immunol. 1997. 99: 530-538.
35. Bellinghousen, I., Metz, G., Enk, A. H., Christmann, S., Knop, J. and Saloga, J., Insect venom immunotherapy induces interleukin-10 production and a Th2-to-Th1 shift, and changes surface marker expression in venom-allergic subjects. Eur. J. Immunol. 1997. 27: 1131-1139.
36. Akdis, A. C., Akdis, M., Blesken, T., Wymann, D., Alkan, S. S. and Blaser, K., Epitope specific T cell tolerance to phospholipase A2 in bee venom immunotherapy and recovery by IL-2 and IL-15 in vitro. J. Clin. Invest. 1996. 98: 1676-1683.
37. Akdis, C. A., Joss, A., Akdis, M., Faith, A. and Blaser, K., A molecular basis for T cell suppression by IL-10: CD28-associated IL-10 receptor inhibits CD28 tyrosine phosphorylation and phosphatidylinositol 3-kinase binding. FASEB J. 2000. 14: 1666-1668.
38. Akdis, C. A. and Blaser, K., IL-10 induced peripheral T cell anergy and reactivation by microenvironmental cytokines: two key steps in specific immunotherapy. FASEB J. 1999. 13: 603-609.
39. Durham, S. R., Walker, S. M., Varga, E. M., Jacobson, M. R., O'Brien, F., Noble, W., Till, S. J., Hamid, Q. A. and Nouri-Aria, K. T., Long-term clinical efficacy of grass-pollen immunotherapy. N. Engl. J. Med. 1999. 341: 468-475.
40. Parker, W. A., Whisman, B. A., Apalinski, S. J. and Reid, M. J., The relationship between cutaneous responses and specific antibody responses with outcome of immunotherapy for seasonal allergic rhinitis. J. Allergy Clin. Immunol. 1989. 84: 667-677.
41. Creticos, R S., The consideration of immunotherapy in the treatment of allergic asthma. J. Allergy Clin. Immunol. 2000. 105: 559-579.
42. Sakaguchi, S., Sakaguchi, N., Asano, M., Itoh, M. and Toda, M., Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor α-chains (CD25). Breakdown of a single mechanism of self tolerance causes various autoimmune diseases. J. Immunol. 1995. 155: 1151-1156.
43. + T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 1997. 389: 737-742.
44. +) regulatory T cells. Curr. Opin. Immunol. 2001. 13: 644-649.
45. Shevach, E. M., Regulatory T cells in autoimmunity. Annu. Rev. Immunol. 2000. 18: 423-449.
46. + T cells inhibit both the induction and effector function of autoreactive T cells and represent a unique lineage of immunoregulatory cells. J. Immunol. 1998. 160: 1212-1218.
47. + immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J. Exp. Med. 1998. 188: 287-296.
48. + T cells with regulatory properties isolated from peripheral blood. J. Exp. Med. 2001. 193:1285-1294.
49. + regulatory T cells. J. Exp. Med. 2001. 194: 847-853.
50. + human thymocytes. J. Exp. Med. 2002. 196: 379-387.
51. Vignola, A. M., Chanez, P., Chiappara, G., Meredino, A., Pace, E., Rizzo, A., LaRocca, A. M., Bellia, V., Bonsignore, G. and Bousquet, J., Transforming growth factor-β expression in mucosal biopsies in asthma and chronic bronchitis. Am. J. Respir. Crit. Care Med. 1997. 156: 591-599.
52. Magnan, A., Retornaz, F., Tsicopoulos, A., Brisse, J., Van Pee, D., Gosse, P., Chamlian, A., Tonnel, A. B. and Vervloet, D., Altered compartmenalization of transforming growth factor-β in asthmatic airways. Clin. Exp. Allergy 1997. 27: 389-395.
53. Fukaura, H., Kent, S. C., Pietrusewicz, M. J., Khoury, S. J., Weiner, H. L. and Hafler, D. A., Induction of circulating myelin basic protein and proteolipid protein-specific transforming growth factor-β1-secreting Th3 T cells by oral administration of myelin in multiple sclerosis patients. J. Clin. Invest. 1996. 98: 70-77.
54. Inobe, J., Slavin, A. J., Komagata, Y., Chen, Y., Liu, L. and Weiner, H. L., IL-4 is a differentiation factor for transforming growth factor-β secreting Th3 cells and oral administration of IL-4 enhances oral tolerance in experimental allergic encephalomyelitis. Eur. J. Immunol. 1998. 28: 2780-2790.
55. Liu, Y., de Waal Malefyt, R., Briere, F., Parham, C., Bridon, J. M., Banchereau, J., Moore, K. W. and Xu, J., The Epstein-Barr virus interleukin-10 (IL-10) homolog is a selective agonist with impaired binding to the IL-10 receptor. J. Immunol. 1997. 158: 604-613.
56. + T cells: a highly differentiated and apoptosis-prone population. Eur. J. Immunol. 2001. 31: 1122-1231.
57. + T helper cells. J. Exp. Med. 2002. 196: 255-260.